
Endocrinologist

No OPD information available
Abdominal Obesity Metabolic Syndrome
Metabolic Syndrome
Obesity
Familial Dysautonomia
High Cholesterol
Hypertension
Postural Orthostatic Tachycardia Syndrome (POTS)
Type 2 Diabetes (T2D)
Nora E. Straznicky is a female healthcare provider who helps patients with different health issues like abdominal obesity, metabolic syndrome, obesity, familial dysautonomia, high cholesterol, hypertension, postural orthostatic tachycardia syndrome (POTS), and type 2 diabetes (T2D).
Nora E. Straznicky works with patients to improve their health and wellbeing. She has special skills in managing conditions like obesity, high cholesterol, and diabetes. Nora listens to her patients carefully and explains things in a way that is easy to understand. Patients trust her because she is caring and knowledgeable about their health concerns.
Nora E. Straznicky stays updated with the latest medical knowledge and research to provide the best care for her patients. She attends conferences, reads medical journals, and collaborates with other healthcare professionals to learn and share information.
Nora E. Straznicky works closely with her colleagues to ensure that patients receive comprehensive care. She values teamwork and communication to provide the best outcomes for her patients. By working together, Nora and her colleagues can offer a holistic approach to healthcare.
Nora E. Straznicky's work has positively impacted many patients' lives. She has helped patients manage their conditions, improve their health, and live better lives. Her dedication and expertise have made a difference in the lives of those she cares for.
One of Nora E. Straznicky's notable publications is "Plasma lipocalin-2/NGAL is stable over 12 weeks and is not modulated by exercise or dieting," published in Scientific Reports in March 2020. She has also been involved in clinical trials to explore new treatments for conditions like schizophrenia.
Overall, Nora E. Straznicky is a compassionate and knowledgeable healthcare provider who is dedicated to helping her patients improve their health and quality of life.
Enrollment Status: Withdrawn
Published: April 24, 2019
Intervention Type: Drug
Study Drug:
Study Phase: Phase 4
